Davenport & CO LLC Meira G Tx Holdings PLC Transaction History

Davenport & CO LLC

$16.3 Billion
Q1 2025

A detailed history of Davenport & CO LLC transactions in Meira G Tx Holdings PLC stock. As of the latest transaction made, Davenport & CO LLC holds 56,200 shares of MGTX stock, worth $294,488. This represents 0.0% of its overall portfolio holdings.

Number of Shares

56,200

Previous 77,200 27.2%

Holding current value

$294,488

Previous $470,000 18.94%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 28, 2025	SELL	$5.71 - $8.25 $119,910 - $173,250	-21,000 Reduced 27.2%	56,200 $381,000
Q4 2024 Jan 24, 2025	BUY	$4.03 - $7.1 $20,150 - $35,500	5,000 Added 6.93%	77,200 $470,000
Q3 2024 Oct 24, 2024	SELL	$3.88 - $5.23 $31,040 - $41,840	-8,000 Reduced 9.98%	72,200 $301,000
Q2 2024 Aug 06, 2024	SELL	$4.21 - $5.81 $21,807 - $30,095	-5,180 Reduced 6.07%	80,200 $337,000
Q1 2024 May 03, 2024	BUY	$5.78 - $7.33 $144,644 - $183,433	25,025 Added 41.46%	85,380 $518,000
Q4 2023 Jan 23, 2024	SELL	$3.6 - $7.15 $14,400 - $28,600	-4,000 Reduced 6.22%	60,355 $423,000
Q3 2023 Oct 17, 2023	BUY	$4.79 - $7.19 $862 - $1,294	180 Added 0.28%	64,355 $315,000
Q2 2023 Jul 20, 2023	BUY	$5.19 - $8.07 $47,618 - $74,042	9,175 Added 16.68%	64,175 $431,000
Q1 2023 Apr 27, 2023	BUY	$5.04 - $8.6 $78,120 - $133,300	15,500 Added 39.24%	55,000 $284,000
Q4 2022 Jan 20, 2023	BUY	$5.8 - $8.98 $40,600 - $62,860	7,000 Added 21.54%	39,500 $0
Q3 2022 Oct 11, 2022	BUY	$7.55 - $11.25 $22,650 - $33,750	3,000 Added 10.17%	32,500 $273,000
Q1 2022 May 02, 2022	SELL	$13.42 - $23.38 $13,420 - $23,380	-1,000 Reduced 3.28%	29,500 $409,000
Q4 2021 Feb 10, 2022	BUY	$12.78 - $23.74 $389,790 - $724,070	30,500 New	30,500 $724,000

Others Institutions Holding MGTX

# of Institutions

119

Shares Held

47.3M

Call Options Held

159K

Put Options Held

38.4K

View Full List

About MeiraGTx Holdings plc

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $236M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

More about MGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account